As of May 23, 2025, Signify Health Inc (SGFY) reports a Gross Margin of 45.33%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Signify Health Inc's Gross Margin
Over recent years, Signify Health Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2022-12-31 | 45.33% |
| 2021-12-31 | 46.18% |
| 2020-12-31 | 49.77% |
| 2019-12-31 | 50.74% |
| 2018-12-31 | 41.91% |
This gradual decrease highlights how Signify Health Inc manages its operational efficiency and pricing power over time.
Comparing Signify Health Inc's Gross Margin to Peers
To better understand Signify Health Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Signify Health Inc (SGFY) | 45.33% |
| Global Cord Blood Corp (CO) | 85.26% |
| Biodesix Inc (BDSX) | 78.17% |
| Cryo-Cell International Inc (CCEL) | 75.15% |
| Heartbeam Inc (BEAT) | 62.70% |
| Viemed Healthcare Inc (VMD.TO) | 61.02% |
Compared to its competitors, Signify Health Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.